PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 1, 2026Journal of Cancer Research and Clinical Oncology1 citationsOpen Access

Diagnostic performance and clinical limitations of sentinel lymph node biopsy in head and neck melanoma: a 20-year retrospective cohort study

LLLukas LükewilleSWSusanne WiegandAFAsita Fazel

Key Points

  • This study aims to assess the long-term diagnostic accuracy of sentinel lymph node biopsy (SLNB) in head and neck melanoma and explore factors associated with false-negative results.
  • Retrospective single-center cohort study of patients with cutaneous head and neck melanoma undergoing SLNB from 2002 to 2022.
  • Patients were divided into two cohorts based on the period received treatment: 2002-2011 and 2012-2022.
  • Calculated detection rates, sensitivity, and false-negative rates; analyzed overall survival with Kaplan–Meier estimates.
  • SLNB detection rate improved from 78.2% in the earlier cohort to 98.0% in the later cohort (p < 0.0001).
  • Overall sensitivity for SLNB was 72.5%, with a false-negative rate of 27.5%.
  • No significant association between sentinel lymph node status and overall survival (p = 0.627).

Abstract

Abstract Purpose Sentinel lymph node biopsy (SLNB) is a standard procedure for nodal staging in cutaneous melanoma. However, its diagnostic performance in the head and neck region remains limited due to complex lymphatic drainage patterns. This study aimed to evaluate the long-term diagnostic accuracy of SLNB in head and neck melanoma and to analyze anatomical and clinical factors associated with false-negative results. Methods This retrospective single-center cohort study included patients with cutaneous head and neck melanoma who underwent SLNB between 2002 and 2022. Patients were stratified into two cohorts (2002–2011 and 2012–2022). Detection rates, sensitivity, negative predictive value, and false-negative rates were calculated. Overall survival was analyzed using Kaplan–Meier estimates and compared by log-rank testing. Results A total of 189 patients were included. Sentinel lymph node detection significantly improved from 78.2% in the earlier cohort to 98.0% in the later cohort ( p < 0.0001). Across the combined cohort, SLNB sensitivity was 72.5%, with a false-negative rate of 27.5%. False-negative events predominantly occurred in anatomically complex drainage regions. Sentinel lymph node status was not significantly associated with overall survival ( p = 0.627). Conclusions Despite substantial improvements in detection rates, SLNB in head and neck melanoma demonstrates clinically relevant limitations in diagnostic sensitivity. The observed false-negative rate highlights a risk of understaging, which may affect eligibility for adjuvant systemic therapies. SLNB findings should therefore be interpreted in the context of anatomical risk patterns and integrated into individualized follow-up strategies. The lack of an association between sentinel lymph node status and overall survival may reflect the impact of modern adjuvant systemic therapies and the distinct biological behavior of head and neck melanoma. However, this finding should be interpreted with caution given the limited sample size. These findings underscore the importance of procedural expertise and risk-adapted surveillance in this anatomically complex region.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lükewille et al. (2026) studied this question.

synapsesocial.com/papers/6a1d236002fbce91306390d6https://doi.org/10.1007/s00432-026-06499-5
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sentinel Node Biopsy for Head and Neck Melanoma: A 12-Year Experience from a Medium-Volume Regional Center2026
  2. 2Accuracy of Sentinel Lymph Node Biopsy to Predict Nodal Metastasis in Head and Neck Merkel Cell Carcinoma2026 · 1 citations
  3. 3The predictive value of the sentinel lymph node biopsy in malignant melanoma of the head and neck in the Kiel patient collective2024
  4. 4False-negative sentinel lymph node biopsy for melanoma: a single-surgeon experience2024 · 1 citations
  5. 5Sentinel lymph node status and oncological outcomes of high-risk and low-risk cutaneous primary melanoma2026